Az interferon-gamma aktivációs utak defektusai: a primer immunhiányos betegségek új csoportja.

Translated title of the contribution: Disorders of interferon-gamma activation pathways: new group of primary immune deficiency diseases

Research output: Contribution to journalReview article

Abstract

Protective immunity to intracellular bacteria such as mycobacteria and salmonella depends on intact cell-mediated immunity. Major effector mechanisms of cell-mediated immunity involve activation of macrophages by T helper-1 cytokines, particularly interferon-gamma. Patients with genetic deficiency of T helper-1 cytokines (IFN-gamma, IL-12) or T helper-1 cytokine receptors (IFN-gamma receptor, IL-12 receptor) are susceptible to infections with poorly pathogenic mycobacteria, and salmonella, suggesting that T helper-1 cytokines are essential in host defense against these pathogens. This review reports on the genetic and clinical characteristics of primary deficiencies of interferon-gamma activation pathways.

Translated title of the contributionDisorders of interferon-gamma activation pathways: new group of primary immune deficiency diseases
Original languageHungarian
Pages (from-to)2557-2561
Number of pages5
JournalOrvosi hetilap
Volume142
Issue number46
Publication statusPublished - Nov 18 2001

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Disorders of interferon-gamma activation pathways: new group of primary immune deficiency diseases'. Together they form a unique fingerprint.

  • Cite this